Silence Therapeutics PLC (SLN) — Free Cash Flow Generation Index
Silence Therapeutics PLC (SLN) has a Free Cash Flow Generation Index of 0.98x as of June 2021. Free cash flow of $25.59 Million represents 1% of operating cash flow ($26.03 Million). See SLN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Silence Therapeutics PLC Free Cash Flow Generation Index (2019–2021)
Historical FCF Generation Index trend for Silence Therapeutics PLC across 2 annual periods. Explore how well can Silence Therapeutics PLC service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Silence Therapeutics PLC (2019–2021)
Year-by-year Free Cash Flow Generation Index for Silence Therapeutics PLC. For the full company profile including market capitalisation, see Silence Therapeutics PLC (SLN) total market value.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | $7.39 Million | $9.19 Million | $1.80 Million | ▼ -19.2% |
| 2019 | 0.99x | $1.72 Million | $1.73 Million | $9.00K | — |